| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR1L8 GIPR VIPR1 VIPR2 IL13RA2 OR51B5 PTPRA PTPRC CSF2RB PTPRF PTPRK OR5AN1 DDR2 OR5B17 GPR52 GPR63 CCR8 GPR183 CALCRL ADGRL2 CR2 GPR176 CHRNA4 CNR1 ADCYAP1R1 NOTCH2 CHRNG OR52E2 | 1.03e-12 | 1353 | 86 | 28 | GO:0004888 |
| GeneOntologyMolecularFunction | vasoactive intestinal polypeptide receptor activity | 7.71e-08 | 3 | 86 | 3 | GO:0004999 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR1L8 GIPR VIPR1 VIPR2 OR51B5 OR5AN1 OR5B17 GPR52 GPR63 CCR8 GPR183 CALCRL ADGRL2 GPR176 CNR1 ADCYAP1R1 OR52E2 | 1.85e-07 | 884 | 86 | 17 | GO:0004930 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 7.31e-07 | 17 | 86 | 4 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 7.31e-07 | 17 | 86 | 4 | GO:0019198 | |
| GeneOntologyMolecularFunction | peptide hormone binding | 3.87e-06 | 55 | 86 | 5 | GO:0017046 | |
| GeneOntologyMolecularFunction | glucan 1,4-alpha-glucosidase activity | 1.83e-05 | 2 | 86 | 2 | GO:0004339 | |
| GeneOntologyMolecularFunction | hormone binding | 8.28e-05 | 103 | 86 | 5 | GO:0042562 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucosidase activity | 1.82e-04 | 5 | 86 | 2 | GO:0004558 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 2.75e-04 | 133 | 86 | 5 | GO:0008528 | |
| GeneOntologyMolecularFunction | amide binding | 3.08e-04 | 299 | 86 | 7 | GO:0033218 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 3.48e-04 | 140 | 86 | 5 | GO:0001653 | |
| GeneOntologyMolecularFunction | alpha-glucosidase activity | 3.80e-04 | 7 | 86 | 2 | GO:0090599 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 1.03e-03 | 103 | 86 | 4 | GO:0004725 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.80e-03 | 120 | 86 | 4 | GO:0008013 | |
| GeneOntologyMolecularFunction | glucosidase activity | 1.86e-03 | 15 | 86 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 2.39e-03 | 17 | 86 | 2 | GO:0022848 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.05e-07 | 187 | 88 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | HFE SDK2 PTPRC EFNB2 PTPRF PCDHGB7 PCDHGB6 ABCA12 CD53 PCDHAC2 TSC2 CD200R1L TNFRSF21 SDK1 CDH8 ITGB8 CDH10 TSPAN9 CDH18 | 1.07e-07 | 1077 | 88 | 19 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 7.60e-06 | 313 | 88 | 9 | GO:0098742 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR1L8 GIPR VIPR1 VIPR2 OR51B5 EREG OR5AN1 OR5B17 GPR52 GPR63 CCR8 GPR183 CALCRL ADGRL2 GPR176 CNR1 ADCYAP1R1 OR52E2 | 2.02e-05 | 1395 | 88 | 18 | GO:0007186 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte mediated cytotoxicity | 2.22e-05 | 79 | 88 | 5 | GO:0001912 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 3.05e-05 | 286 | 88 | 8 | GO:0007188 | |
| GeneOntologyBiologicalProcess | positive regulation of cell killing | 3.74e-05 | 88 | 88 | 5 | GO:0031343 | |
| GeneOntologyBiologicalProcess | cell activation | HFE IL13RA2 SLAMF6 PTPRC EFNB2 CD226 DDR2 TSC2 GPR183 DYSF CR2 TNFRSF21 ITGB8 CHRNA4 TSPAN9 CNR1 NOTCH2 | 5.14e-05 | 1356 | 88 | 17 | GO:0001775 |
| GeneOntologyBiologicalProcess | adherens junction organization | 1.34e-04 | 61 | 88 | 4 | GO:0034332 | |
| GeneOntologyBiologicalProcess | leukocyte activation | HFE IL13RA2 SLAMF6 PTPRC EFNB2 CD226 TSC2 GPR183 DYSF CR2 TNFRSF21 ITGB8 CHRNA4 CNR1 NOTCH2 | 1.38e-04 | 1186 | 88 | 15 | GO:0045321 |
| GeneOntologyBiologicalProcess | cell junction assembly | SLC25A46 SDK2 PTPRA EFNB2 PTPRK ADGRL2 SDK1 CDH8 CDH10 CDH18 | 1.54e-04 | 569 | 88 | 10 | GO:0034329 |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.90e-04 | 124 | 88 | 5 | GO:0001910 | |
| GeneOntologyBiologicalProcess | B cell proliferation | 1.90e-04 | 124 | 88 | 5 | GO:0042100 | |
| GeneOntologyBiologicalProcess | keratinocyte proliferation | 2.29e-04 | 70 | 88 | 4 | GO:0043616 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated immunity | 3.56e-04 | 309 | 88 | 7 | GO:0002703 | |
| GeneOntologyBiologicalProcess | protein localization to cell surface | 3.64e-04 | 79 | 88 | 4 | GO:0034394 | |
| GeneOntologyBiologicalProcess | positive regulation of Fc receptor mediated stimulatory signaling pathway | 3.73e-04 | 7 | 88 | 2 | GO:0060369 | |
| GeneOntologyBiologicalProcess | regulation of B cell proliferation | 3.82e-04 | 80 | 88 | 4 | GO:0030888 | |
| GeneOntologyBiologicalProcess | regulation of cell killing | 4.18e-04 | 147 | 88 | 5 | GO:0031341 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte activation | 4.39e-04 | 320 | 88 | 7 | GO:0002274 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte mediated immunity | 4.59e-04 | 150 | 88 | 5 | GO:0002708 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte mediated immunity | 4.77e-04 | 232 | 88 | 6 | GO:0002706 | |
| GeneOntologyBiologicalProcess | protein localization to endoplasmic reticulum exit site | 4.96e-04 | 8 | 88 | 2 | GO:0070973 | |
| GeneOntologyCellularComponent | receptor complex | HFE VIPR1 IL13RA2 PTPRA CSF2RB DDR2 GPR63 CALCRL CD200R1L CR2 ITGB8 CHRNA4 ADCYAP1R1 NOTCH2 CHRNG | 2.55e-08 | 581 | 90 | 15 | GO:0043235 |
| GeneOntologyCellularComponent | cell surface | HFE IL13RA2 CD1E SLAMF6 PTPRC CSF2RB PTPRK CD226 AOC3 CD53 CCR8 CD200R1L VAMP4 CR2 ITGB8 CHRNA4 ADCYAP1R1 NOTCH2 IGSF3 | 2.05e-07 | 1111 | 90 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | HFE IL13RA2 CD1E SLAMF6 PTPRC CSF2RB CD226 CCR8 CD200R1L CR2 CHRNA4 | 1.41e-05 | 519 | 90 | 11 | GO:0009897 |
| GeneOntologyCellularComponent | synaptic membrane | 2.04e-04 | 583 | 90 | 10 | GO:0097060 | |
| GeneOntologyCellularComponent | anchoring junction | GJD2 PTPRA PTPRC EFNB2 PTPRK DDR2 CD53 CDH8 ITGB8 CDH10 TSPAN9 ADCYAP1R1 CDH18 | 2.70e-04 | 976 | 90 | 13 | GO:0070161 |
| GeneOntologyCellularComponent | catenin complex | 3.50e-04 | 32 | 90 | 3 | GO:0016342 | |
| GeneOntologyCellularComponent | side of membrane | HFE IL13RA2 CD1E SLAMF6 BCAP31 PTPRC CSF2RB CD226 CCR8 CD200R1L CR2 CHRNA4 | 3.65e-04 | 875 | 90 | 12 | GO:0098552 |
| GeneOntologyCellularComponent | plasma membrane protein complex | HFE GJD2 CSF2RB SGCB CALCRL CDH8 ITGB8 CDH10 CHRNA4 CDH18 CHRNG | 5.45e-04 | 785 | 90 | 11 | GO:0098797 |
| GeneOntologyCellularComponent | lysosome | GPR155 CD1E SLC36A4 LAPTM4B SLC44A2 TSC2 MFSD8 CALCRL TM6SF1 VAMP4 TMEM9B | 7.14e-04 | 811 | 90 | 11 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | GPR155 CD1E SLC36A4 LAPTM4B SLC44A2 TSC2 MFSD8 CALCRL TM6SF1 VAMP4 TMEM9B | 7.14e-04 | 811 | 90 | 11 | GO:0000323 |
| GeneOntologyCellularComponent | lysosomal membrane | 8.53e-04 | 462 | 90 | 8 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 8.53e-04 | 462 | 90 | 8 | GO:0098852 | |
| GeneOntologyCellularComponent | membrane microdomain | 9.92e-04 | 364 | 90 | 7 | GO:0098857 | |
| GeneOntologyCellularComponent | vacuolar membrane | 1.54e-03 | 507 | 90 | 8 | GO:0005774 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.83e-03 | 405 | 90 | 7 | GO:0045211 | |
| GeneOntologyCellularComponent | vacuole | GPR155 CD1E SLC36A4 LAPTM4B SLC44A2 TSC2 MFSD8 CALCRL TM6SF1 VAMP4 TMEM9B | 1.85e-03 | 913 | 90 | 11 | GO:0005773 |
| GeneOntologyCellularComponent | adherens junction | 2.24e-03 | 212 | 90 | 5 | GO:0005912 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 2.68e-03 | 18 | 90 | 2 | GO:0005892 | |
| GeneOntologyCellularComponent | cell-cell junction | 3.96e-03 | 591 | 90 | 8 | GO:0005911 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 4.04e-03 | 350 | 90 | 6 | GO:0098802 | |
| GeneOntologyCellularComponent | membrane protein complex | HFE GJD2 CSF2RB SGCB LRRC8B MFSD8 CALCRL VAMP4 CDH8 ITGB8 CDH10 CHRNA4 CDH18 CHRNG | 4.70e-03 | 1498 | 90 | 14 | GO:0098796 |
| GeneOntologyCellularComponent | membrane raft | 4.76e-03 | 362 | 90 | 6 | GO:0045121 | |
| Domain | HormR | 1.32e-09 | 25 | 86 | 6 | SM00008 | |
| Domain | HRM | 2.77e-09 | 28 | 86 | 6 | PF02793 | |
| Domain | GPCR_2_secretin-like_CS | 9.68e-09 | 34 | 86 | 6 | IPR017983 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 2.70e-08 | 40 | 86 | 6 | PS00649 | |
| Domain | GPCR_2_extracellular_dom | 2.70e-08 | 40 | 86 | 6 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 2.70e-08 | 40 | 86 | 6 | PS50227 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.08e-07 | 50 | 86 | 6 | PS00650 | |
| Domain | 7tm_2 | 1.08e-07 | 50 | 86 | 6 | PF00002 | |
| Domain | GPCR_2_secretin-like | 3.28e-07 | 60 | 86 | 6 | IPR000832 | |
| Domain | GPCR_2-like | 3.28e-07 | 60 | 86 | 6 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 3.62e-07 | 61 | 86 | 6 | PS50261 | |
| Domain | - | HFE IL13RA2 CD1E SLAMF6 SDK2 PTPRC CSF2RB PTPRF PTPRK CD226 CD200R1L SDK1 IGSF3 | 1.01e-05 | 663 | 86 | 13 | 2.60.40.10 |
| Domain | Cadherin_CS | 1.11e-05 | 109 | 86 | 6 | IPR020894 | |
| Domain | CADHERIN_1 | 1.36e-05 | 113 | 86 | 6 | PS00232 | |
| Domain | Cadherin | 1.36e-05 | 113 | 86 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 1.43e-05 | 114 | 86 | 6 | PS50268 | |
| Domain | - | 1.43e-05 | 114 | 86 | 6 | 2.60.40.60 | |
| Domain | CA | 1.50e-05 | 115 | 86 | 6 | SM00112 | |
| Domain | Cadherin-like | 1.58e-05 | 116 | 86 | 6 | IPR015919 | |
| Domain | Cadherin | 1.74e-05 | 118 | 86 | 6 | IPR002126 | |
| Domain | Ig-like_fold | HFE IL13RA2 CD1E SLAMF6 SDK2 PTPRC CSF2RB PTPRF PTPRK CD226 CD200R1L SDK1 IGSF3 | 1.97e-05 | 706 | 86 | 13 | IPR013783 |
| Domain | GPCR_2_VIP_rcpt | 2.10e-05 | 2 | 86 | 2 | IPR001571 | |
| Domain | BAP29/BAP31 | 2.10e-05 | 2 | 86 | 2 | IPR008417 | |
| Domain | Bap31 | 2.10e-05 | 2 | 86 | 2 | PF05529 | |
| Domain | PTPc | 2.21e-05 | 36 | 86 | 4 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 3.05e-05 | 39 | 86 | 4 | PS50055 | |
| Domain | FN3 | 3.70e-05 | 199 | 86 | 7 | PS50853 | |
| Domain | PTPase_domain | 3.73e-05 | 41 | 86 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 3.73e-05 | 41 | 86 | 4 | PF00102 | |
| Domain | FN3_dom | 5.05e-05 | 209 | 86 | 7 | IPR003961 | |
| Domain | IG_LIKE | 8.52e-05 | 491 | 86 | 10 | PS50835 | |
| Domain | fn3 | 1.03e-04 | 162 | 86 | 6 | PF00041 | |
| Domain | Ig-like_dom | 1.04e-04 | 503 | 86 | 10 | IPR007110 | |
| Domain | NtCtMGAM_N | 1.25e-04 | 4 | 86 | 2 | PF16863 | |
| Domain | Gal_mutarotase_N | 1.25e-04 | 4 | 86 | 2 | IPR031727 | |
| Domain | PTPc_motif | 1.57e-04 | 59 | 86 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.57e-04 | 59 | 86 | 4 | IPR003595 | |
| Domain | Cadherin_cytoplasmic-dom | 2.01e-04 | 25 | 86 | 3 | IPR000233 | |
| Domain | Cadherin_C | 2.01e-04 | 25 | 86 | 3 | PF01049 | |
| Domain | FerI | 2.08e-04 | 5 | 86 | 2 | SM01202 | |
| Domain | FerB | 2.08e-04 | 5 | 86 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 2.08e-04 | 5 | 86 | 2 | IPR012561 | |
| Domain | Ferlin_C | 2.08e-04 | 5 | 86 | 2 | PF16165 | |
| Domain | Ferlin_C | 2.08e-04 | 5 | 86 | 2 | IPR032362 | |
| Domain | FerIin_dom | 2.08e-04 | 5 | 86 | 2 | IPR012968 | |
| Domain | FerI | 2.08e-04 | 5 | 86 | 2 | PF08151 | |
| Domain | FerB | 2.08e-04 | 5 | 86 | 2 | PF08150 | |
| Domain | FN3 | 2.12e-04 | 185 | 86 | 6 | SM00060 | |
| Domain | GPCR_Rhodpsn_7TM | OR1L8 OR51B5 OR5AN1 OR5B17 GPR52 GPR63 CCR8 GPR183 GPR176 CNR1 OR52E2 | 2.47e-04 | 670 | 86 | 11 | IPR017452 |
| Domain | 7tm_1 | OR1L8 OR51B5 OR5AN1 OR5B17 GPR52 GPR63 CCR8 GPR183 GPR176 CNR1 OR52E2 | 2.70e-04 | 677 | 86 | 11 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR1L8 OR51B5 OR5AN1 OR5B17 GPR52 GPR63 CCR8 GPR183 GPR176 CNR1 OR52E2 | 2.99e-04 | 685 | 86 | 11 | PS00237 |
| Domain | Glyco_hydro_31_AS | 3.11e-04 | 6 | 86 | 2 | IPR030458 | |
| Domain | Catenin_binding_dom | 3.16e-04 | 29 | 86 | 3 | IPR027397 | |
| Domain | - | 3.16e-04 | 29 | 86 | 3 | 4.10.900.10 | |
| Domain | G_PROTEIN_RECEP_F1_2 | OR1L8 OR51B5 OR5AN1 OR5B17 GPR52 GPR63 CCR8 GPR183 GPR176 CNR1 OR52E2 | 3.22e-04 | 691 | 86 | 11 | PS50262 |
| Domain | GPCR_Rhodpsn | OR1L8 OR51B5 OR5AN1 OR5B17 GPR52 GPR63 CCR8 GPR183 GPR176 CNR1 OR52E2 | 3.26e-04 | 692 | 86 | 11 | IPR000276 |
| Domain | Tyr_Pase_AS | 3.58e-04 | 73 | 86 | 4 | IPR016130 | |
| Domain | Glyco_hydro_31 | 4.34e-04 | 7 | 86 | 2 | IPR000322 | |
| Domain | Glyco_hydro_31 | 4.34e-04 | 7 | 86 | 2 | PF01055 | |
| Domain | GLYCOSYL_HYDROL_F31_1 | 4.34e-04 | 7 | 86 | 2 | PS00129 | |
| Domain | Trefoil | 5.76e-04 | 8 | 86 | 2 | PF00088 | |
| Domain | Cadherin_tail | 6.54e-04 | 37 | 86 | 3 | PF15974 | |
| Domain | Cadherin_CBD | 6.54e-04 | 37 | 86 | 3 | IPR031904 | |
| Domain | TYR_PHOSPHATASE_1 | 6.68e-04 | 86 | 86 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 6.97e-04 | 87 | 86 | 4 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 6.97e-04 | 87 | 86 | 4 | IPR000387 | |
| Domain | P_TREFOIL_2 | 7.39e-04 | 9 | 86 | 2 | PS51448 | |
| Domain | PD | 7.39e-04 | 9 | 86 | 2 | SM00018 | |
| Domain | - | 8.60e-04 | 92 | 86 | 4 | 3.90.190.10 | |
| Domain | Cadherin_C | 9.50e-04 | 42 | 86 | 3 | IPR032455 | |
| Domain | Cadherin_C_2 | 9.50e-04 | 42 | 86 | 3 | PF16492 | |
| Domain | - | 1.12e-03 | 11 | 86 | 2 | 4.10.110.10 | |
| Domain | IL6Ra-bind | 1.12e-03 | 11 | 86 | 2 | PF09240 | |
| Domain | TypeI_recpt_CBD | 1.12e-03 | 11 | 86 | 2 | IPR015321 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.13e-03 | 99 | 86 | 4 | IPR029021 | |
| Domain | P_trefoil_dom | 1.34e-03 | 12 | 86 | 2 | IPR000519 | |
| Domain | Nicotinic_acetylcholine_rcpt | 2.41e-03 | 16 | 86 | 2 | IPR002394 | |
| Domain | Gal_mutarotase_SF_dom | 2.72e-03 | 17 | 86 | 2 | IPR011013 | |
| Domain | IG | 3.28e-03 | 421 | 86 | 7 | SM00409 | |
| Domain | Ig_sub | 3.28e-03 | 421 | 86 | 7 | IPR003599 | |
| Domain | Cadherin_2 | 3.35e-03 | 65 | 86 | 3 | PF08266 | |
| Domain | Cadherin_N | 3.35e-03 | 65 | 86 | 3 | IPR013164 | |
| Domain | Tetraspanin_CS | 4.16e-03 | 21 | 86 | 2 | IPR018503 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 1.26e-09 | 24 | 68 | 6 | M39643 | |
| Pathway | WP_GPCRS_CLASS_B_SECRETINLIKE | 1.26e-09 | 24 | 68 | 6 | MM15992 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 3.28e-06 | 48 | 68 | 5 | MM15069 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 1.00e-05 | 60 | 68 | 5 | MM14964 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 1.82e-05 | 33 | 68 | 4 | MM15066 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 1.82e-05 | 33 | 68 | 4 | M10322 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 2.62e-05 | 73 | 68 | 5 | MM15126 | |
| Pathway | WP_GPCRS_NONODORANT | 4.02e-05 | 266 | 68 | 8 | MM15843 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 4.70e-05 | 272 | 68 | 8 | M13380 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 6.40e-05 | 143 | 68 | 6 | MM15055 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 7.20e-05 | 90 | 68 | 5 | M820 | |
| Pathway | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | 8.86e-05 | 94 | 68 | 5 | M797 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 9.79e-05 | 96 | 68 | 5 | MM14592 | |
| Pathway | REACTOME_G_ALPHA_S_SIGNALLING_EVENTS | 1.07e-04 | 157 | 68 | 6 | M4904 | |
| Pathway | WP_SIDS_SUSCEPTIBILITY_PATHWAYS | 1.85e-04 | 59 | 68 | 4 | MM15838 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 2.48e-04 | 117 | 68 | 5 | M19248 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 4.74e-04 | 7 | 68 | 2 | M27596 | |
| Pathway | REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS | 4.74e-04 | 7 | 68 | 2 | MM15311 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 8.08e-04 | 9 | 68 | 2 | M47622 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 8.99e-04 | 155 | 68 | 5 | M522 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 9.33e-04 | 40 | 68 | 3 | MM15060 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 1.01e-03 | 10 | 68 | 2 | MM1354 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 1.05e-03 | 430 | 68 | 8 | MM15160 | |
| Pathway | WP_GPCRS_OTHER | 1.05e-03 | 93 | 68 | 4 | M39629 | |
| Pathway | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 1.47e-03 | 12 | 68 | 2 | M48008 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 1.67e-03 | 463 | 68 | 8 | M507 | |
| Pathway | BIOCARTA_BLYMPHOCYTE_PATHWAY | 2.01e-03 | 14 | 68 | 2 | M1473 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 2.01e-03 | 14 | 68 | 2 | M757 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 2.31e-03 | 15 | 68 | 2 | MM14704 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 8.65e-09 | 101 | 90 | 7 | 23382219 | |
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 36430275 | ||
| Pubmed | 1.68e-08 | 3 | 90 | 3 | 20026142 | ||
| Pubmed | IL-6 and PACAP receptor expression and localization after global brain ischemia in mice. | 6.69e-08 | 4 | 90 | 3 | 22669509 | |
| Pubmed | 7.45e-08 | 16 | 90 | 4 | 8875997 | ||
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 12417650 | ||
| Pubmed | 1.67e-07 | 5 | 90 | 3 | 20449688 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | CERS2 VIPR2 TMEM62 BCAP31 PTPRA BCAP29 SGCB LAPTM4B SLC44A2 CCR8 SLC29A1 NOTCH2 | 2.51e-07 | 697 | 90 | 12 | 28298427 |
| Pubmed | PACAP/PAC1 autocrine system promotes proliferation and astrogenesis in neural progenitor cells. | 3.33e-07 | 6 | 90 | 3 | 17115416 | |
| Pubmed | 3.33e-07 | 6 | 90 | 3 | 22700375 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | CERS2 HFE TMEM156 BCAP31 PTPRA PTPRF SGCB FAM20B PCDHAC2 C11orf24 MFSD8 VAMP4 TNFRSF21 NOTCH2 | 5.81e-07 | 1061 | 90 | 14 | 33845483 |
| Pubmed | 5.82e-07 | 7 | 90 | 3 | 1454056 | ||
| Pubmed | 5.82e-07 | 7 | 90 | 3 | 12376545 | ||
| Pubmed | 9.34e-07 | 200 | 90 | 7 | 18240029 | ||
| Pubmed | 1.10e-06 | 70 | 90 | 5 | 12036966 | ||
| Pubmed | 1.28e-06 | 132 | 90 | 6 | 26439863 | ||
| Pubmed | 1.98e-06 | 10 | 90 | 3 | 10861224 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HFE NEMP1 BCAP31 PTPRF PTPRK BCAP29 SGCB TMEM245 FAM20B TSC2 SLC29A1 ITGB8 NOTCH2 IGSF3 | 2.49e-06 | 1201 | 90 | 14 | 35696571 |
| Pubmed | 3.62e-06 | 12 | 90 | 3 | 22102170 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 4.05e-06 | 91 | 90 | 5 | 28558017 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17077178 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17883247 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 19650041 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 9748473 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 16572459 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 11160313 | ||
| Pubmed | VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans. | 6.62e-06 | 2 | 90 | 2 | 20395540 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 1695146 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 8933357 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 8892388 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 8784257 | ||
| Pubmed | Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy. | 6.62e-06 | 2 | 90 | 2 | 15213259 | |
| Pubmed | Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia. | 6.62e-06 | 2 | 90 | 2 | 11930171 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 22961270 | ||
| Pubmed | Alterations of vasoactive intestinal polypeptide receptors in allergic rhinitis. | 6.62e-06 | 2 | 90 | 2 | 21711977 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 24748662 | ||
| Pubmed | VIP impairs acquisition of the macrophage proinflammatory polarization profile. | 6.62e-06 | 2 | 90 | 2 | 27381006 | |
| Pubmed | Definition of the critical domains required for homophilic targeting of mouse sidekick molecules. | 6.62e-06 | 2 | 90 | 2 | 15703275 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 30150416 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 16552823 | ||
| Pubmed | Radical reversal of vasoactive intestinal peptide (VIP) receptors during early lymphopoiesis. | 6.62e-06 | 2 | 90 | 2 | 21878358 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 33146556 | ||
| Pubmed | Expression of vasoactive intestinal peptide (VIP) receptors in human uterus. | 6.62e-06 | 2 | 90 | 2 | 11072126 | |
| Pubmed | Gene expression of vasoactive intestinal peptide receptors in human lung cancer. | 6.62e-06 | 2 | 90 | 2 | 21769421 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 17507376 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 16934434 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 16934466 | ||
| Pubmed | Two new proteins preferentially associated with membrane immunoglobulin D. | 6.62e-06 | 2 | 90 | 2 | 8070407 | |
| Pubmed | Immunohistochemical localization and distribution of VIP/PACAP receptors in human lung. | 6.62e-06 | 2 | 90 | 2 | 10764955 | |
| Pubmed | Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina. | 6.62e-06 | 2 | 90 | 2 | 12230981 | |
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 20537985 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 31089161 | ||
| Pubmed | 6.62e-06 | 2 | 90 | 2 | 36328148 | ||
| Pubmed | Molecular basis of sidekick-mediated cell-cell adhesion and specificity. | 6.62e-06 | 2 | 90 | 2 | 27644106 | |
| Pubmed | 7.44e-06 | 179 | 90 | 6 | 18577758 | ||
| Pubmed | 7.45e-06 | 15 | 90 | 3 | 33833667 | ||
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 1.11e-05 | 17 | 90 | 3 | 19727691 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 27160938 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 20505149 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 22059987 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 22763881 | ||
| Pubmed | Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer. | 1.98e-05 | 3 | 90 | 2 | 20691743 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 18059271 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 26881970 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 9535845 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 21295288 | ||
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 17500057 | ||
| Pubmed | Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2. | 1.98e-05 | 3 | 90 | 2 | 15047175 | |
| Pubmed | 1.98e-05 | 3 | 90 | 2 | 23684890 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 12886015 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 8759740 | ||
| Pubmed | Select cognitive deficits in vasoactive intestinal peptide deficient mice. | 3.96e-05 | 4 | 90 | 2 | 18616823 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 19269029 | ||
| Pubmed | Gpr176 is a Gz-linked orphan G-protein-coupled receptor that sets the pace of circadian behaviour. | 3.96e-05 | 4 | 90 | 2 | 26882873 | |
| Pubmed | Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis. | 3.96e-05 | 4 | 90 | 2 | 24821911 | |
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 29155851 | ||
| Pubmed | 3.96e-05 | 4 | 90 | 2 | 8980254 | ||
| Pubmed | VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling. | 4.69e-05 | 27 | 90 | 3 | 21737879 | |
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 5.43e-05 | 79 | 90 | 4 | 12679517 | |
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | IL13RA2 SLAMF6 BCAP29 CD226 FAM20B CD53 CCR8 CR2 TNFRSF21 ITGB8 | 5.47e-05 | 824 | 90 | 10 | 20237496 |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 5.74e-05 | 377 | 90 | 7 | 38117590 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | CERS2 BCAP31 PTPRF PTPRK BCAP29 DDR2 FAM20B TP53I11 SLC29A1 TSPAN9 NOTCH2 IGSF3 | 6.33e-05 | 1203 | 90 | 12 | 29180619 |
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 10777529 | ||
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 18180309 | ||
| Pubmed | Macrophage Resistance to HIV-1 Infection Is Enhanced by the Neuropeptides VIP and PACAP. | 6.59e-05 | 5 | 90 | 2 | 23818986 | |
| Pubmed | Ex vivo stretch reveals altered mechanical properties of isolated dystrophin-deficient hearts. | 6.59e-05 | 5 | 90 | 2 | 22427904 | |
| Pubmed | The cell adhesion molecule Sdk1 shapes assembly of a retinal circuit that detects localized edges. | 6.59e-05 | 5 | 90 | 2 | 34545809 | |
| Pubmed | Synergism between NF-kappa B1/p50 and Notch2 during the development of marginal zone B lymphocytes. | 6.59e-05 | 5 | 90 | 2 | 17579038 | |
| Pubmed | Interaction of Bap31 and MHC class I molecules and their traffic out of the endoplasmic reticulum. | 6.59e-05 | 5 | 90 | 2 | 19342655 | |
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 20150284 | ||
| Pubmed | 6.59e-05 | 5 | 90 | 2 | 2169617 | ||
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 30687002 | ||
| Pubmed | Reporter-nanobody fusions (RANbodies) as versatile, small, sensitive immunohistochemical reagents. | 9.87e-05 | 6 | 90 | 2 | 29440485 | |
| Pubmed | 9.87e-05 | 6 | 90 | 2 | 35379807 | ||
| Pubmed | 1.33e-04 | 300 | 90 | 6 | 19086053 | ||
| Pubmed | Characterization of cadherins expressed by murine thymocytes. | 1.38e-04 | 7 | 90 | 2 | 8620560 | |
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 26417101 | ||
| Pubmed | Common pathological mechanisms in mouse models for muscular dystrophies. | 1.38e-04 | 7 | 90 | 2 | 16306063 | |
| Pubmed | Transmembrane homodimerization of receptor-like protein tyrosine phosphatases. | 1.38e-04 | 7 | 90 | 2 | 15978577 | |
| Pubmed | 1.38e-04 | 7 | 90 | 2 | 1932742 | ||
| Interaction | LGALS1 interactions | VIPR2 EREG SDK2 PTPRA PTPRC PTPRK C11orf87 CR2 SDK1 NOTCH2 IGSF3 | 1.02e-07 | 332 | 82 | 11 | int:LGALS1 |
| Interaction | RAB2A interactions | BCAP31 TMEM17 EFNB2 PTPRF BCAP29 MFSD8 TMEM222 VAMP4 ADGRL2 SLC29A1 NOTCH2 IGSF3 | 3.02e-06 | 567 | 82 | 12 | int:RAB2A |
| Interaction | SAAL1 interactions | 1.12e-05 | 187 | 82 | 7 | int:SAAL1 | |
| Interaction | LMBR1 interactions | 1.65e-05 | 78 | 82 | 5 | int:LMBR1 | |
| Interaction | RETREG3 interactions | 3.38e-05 | 222 | 82 | 7 | int:RETREG3 | |
| Interaction | VKORC1L1 interactions | 5.23e-05 | 99 | 82 | 5 | int:VKORC1L1 | |
| Interaction | PTPRA interactions | 5.57e-05 | 164 | 82 | 6 | int:PTPRA | |
| Interaction | GPAT3 interactions | 6.03e-05 | 102 | 82 | 5 | int:GPAT3 | |
| Interaction | EBP interactions | 6.98e-05 | 249 | 82 | 7 | int:EBP | |
| Interaction | LGALS3 interactions | 7.28e-05 | 340 | 82 | 8 | int:LGALS3 | |
| Interaction | NETO2 interactions | 7.41e-05 | 55 | 82 | 4 | int:NETO2 | |
| Interaction | BSCL2 interactions | 1.12e-04 | 186 | 82 | 6 | int:BSCL2 | |
| Interaction | YIPF3 interactions | 1.12e-04 | 186 | 82 | 6 | int:YIPF3 | |
| Interaction | BRICD5 interactions | 1.41e-04 | 194 | 82 | 6 | int:BRICD5 | |
| Interaction | GPR108 interactions | 1.58e-04 | 26 | 82 | 3 | int:GPR108 | |
| Interaction | LAMTOR1 interactions | SLC25A46 CERS2 EFNB2 PTPRF TSC2 MFSD8 VAMP4 ADGRL2 SLC29A1 NOTCH2 IGSF3 | 1.60e-04 | 722 | 82 | 11 | int:LAMTOR1 |
| Interaction | MARCHF1 interactions | 1.90e-04 | 70 | 82 | 4 | int:MARCHF1 | |
| Interaction | P2RX2 interactions | 1.90e-04 | 70 | 82 | 4 | int:P2RX2 | |
| Interaction | ARL4C interactions | 2.34e-04 | 136 | 82 | 5 | int:ARL4C | |
| Interaction | IL13RA2 interactions | 2.34e-04 | 136 | 82 | 5 | int:IL13RA2 | |
| Interaction | SYNGR2 interactions | 2.48e-04 | 75 | 82 | 4 | int:SYNGR2 | |
| Interaction | CLRN2 interactions | 2.61e-04 | 76 | 82 | 4 | int:CLRN2 | |
| Interaction | PCDHA9 interactions | 2.96e-04 | 32 | 82 | 3 | int:PCDHA9 | |
| Interaction | ARL13B interactions | 3.15e-04 | 318 | 82 | 7 | int:ARL13B | |
| Interaction | TMX4 interactions | 3.18e-04 | 80 | 82 | 4 | int:TMX4 | |
| Interaction | EI24 interactions | 4.20e-04 | 86 | 82 | 4 | int:EI24 | |
| Interaction | SLC22A16 interactions | 4.21e-04 | 36 | 82 | 3 | int:SLC22A16 | |
| Interaction | RHOQ interactions | 4.34e-04 | 442 | 82 | 8 | int:RHOQ | |
| Interaction | CDH6 interactions | 4.51e-04 | 8 | 82 | 2 | int:CDH6 | |
| Interaction | ADCYAP1 interactions | 4.57e-04 | 37 | 82 | 3 | int:ADCYAP1 | |
| Interaction | STX6 interactions | 4.74e-04 | 448 | 82 | 8 | int:STX6 | |
| Interaction | IPO11 interactions | 4.80e-04 | 159 | 82 | 5 | int:IPO11 | |
| Interaction | CHRNA4 interactions | 4.80e-04 | 159 | 82 | 5 | int:CHRNA4 | |
| Interaction | MSMO1 interactions | 4.99e-04 | 90 | 82 | 4 | int:MSMO1 | |
| Interaction | VEZT interactions | 5.23e-04 | 162 | 82 | 5 | int:VEZT | |
| Interaction | TYK2 interactions | 5.53e-04 | 164 | 82 | 5 | int:TYK2 | |
| Interaction | RABL3 interactions | 5.53e-04 | 164 | 82 | 5 | int:RABL3 | |
| Interaction | ITPRIPL1 interactions | 5.75e-04 | 40 | 82 | 3 | int:ITPRIPL1 | |
| Interaction | RHBDL2 interactions | 5.78e-04 | 9 | 82 | 2 | int:RHBDL2 | |
| Interaction | RHOB interactions | SDK2 EFNB2 PTPRF PTPRK DDR2 TSC2 ADGRL2 SDK1 SLC29A1 NOTCH2 IGSF3 | 5.80e-04 | 840 | 82 | 11 | int:RHOB |
| Interaction | GJA1 interactions | 5.98e-04 | 583 | 82 | 9 | int:GJA1 | |
| Interaction | OSBPL5 interactions | 6.19e-04 | 41 | 82 | 3 | int:OSBPL5 | |
| Interaction | GLRB interactions | 6.19e-04 | 41 | 82 | 3 | int:GLRB | |
| Interaction | MCAM interactions | 6.32e-04 | 468 | 82 | 8 | int:MCAM | |
| Cytoband | 3p22 | 2.92e-04 | 13 | 90 | 2 | 3p22 | |
| Cytoband | 1p13 | 5.07e-04 | 17 | 90 | 2 | 1p13 | |
| Cytoband | 5q31 | 1.53e-03 | 115 | 90 | 3 | 5q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p14 | 2.42e-03 | 37 | 90 | 2 | chr5p14 | |
| GeneFamily | Vasoactive intestinal peptide receptor family | 4.23e-08 | 3 | 64 | 3 | 264 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 8.17e-07 | 21 | 64 | 4 | 813 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | IL13RA2 CD1E SLAMF6 PTPRC CSF2RB CD226 CD53 CCR8 CR2 TNFRSF21 | 1.14e-06 | 394 | 64 | 10 | 471 |
| GeneFamily | CD molecules|Type II classical cadherins | 1.18e-05 | 13 | 64 | 3 | 1186 | |
| GeneFamily | Fibronectin type III domain containing | 2.15e-05 | 160 | 64 | 6 | 555 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 1.67e-04 | 78 | 64 | 4 | 262 | |
| GeneFamily | Ferlin family | 1.83e-04 | 6 | 64 | 2 | 828 | |
| GeneFamily | Immunoglobulin like domain containing | 6.02e-04 | 193 | 64 | 5 | 594 | |
| GeneFamily | Cholinergic receptors nicotinic subunits | 1.43e-03 | 16 | 64 | 2 | 173 | |
| GeneFamily | Clustered protocadherins | 1.51e-03 | 64 | 64 | 3 | 20 | |
| GeneFamily | CD molecules|Tetraspanins | 6.07e-03 | 33 | 64 | 2 | 768 | |
| GeneFamily | C1-set domain containing | 9.70e-03 | 42 | 64 | 2 | 591 | |
| GeneFamily | Solute carriers | 1.29e-02 | 395 | 64 | 5 | 752 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.94e-02 | 161 | 64 | 3 | 593 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.01e-02 | 163 | 64 | 3 | 590 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | CERS2 BCAP31 PTPRF PTPRK TMEM245 LAPTM4B SLC44A2 ADGRL2 TNFRSF21 SLC29A1 TSPAN9 | 1.57e-05 | 681 | 87 | 11 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | CERS2 BCAP31 PTPRF PTPRK TMEM245 LAPTM4B SLC44A2 ADGRL2 TNFRSF21 SLC29A1 TSPAN9 | 2.10e-05 | 703 | 87 | 11 | MM1055 |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | 4.76e-05 | 507 | 87 | 9 | MM1030 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN | 5.53e-05 | 200 | 87 | 6 | M8039 | |
| Coexpression | GSE2585_CD80_HIGH_VS_LOW_MTEC_UP | 5.53e-05 | 200 | 87 | 6 | M6276 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN | 5.53e-05 | 200 | 87 | 6 | M7150 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-1|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.43e-09 | 183 | 89 | 8 | cd00e2cd901df4b3f5f7aed747cc0b47f6d3c811 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-08 | 174 | 89 | 7 | 8bdf5a97faf1cf0426d1a8851f8a3e27578f7598 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.05e-08 | 174 | 89 | 7 | fbf998dd33ac27dad7639ea85fca393ba2835307 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-08 | 177 | 89 | 7 | b07e6139618d888a9fd7cf43cad0d86a3f63e09e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-B_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-08 | 177 | 89 | 7 | 6376ec12322c04d5d37ec2fdc376700464cbc7fb | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.27e-07 | 194 | 89 | 7 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-07 | 195 | 89 | 7 | 23ced69fd904f1d4114b1a7f99f4b5f65ea8824b | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-07 | 195 | 89 | 7 | 3969b8d5fcec8ef1831531a781f7bbcebab5a4ba | |
| ToppCell | Endothelial-capillary_endothelial_cell_(Cap1)|World / Lineage, Cell type, age group and donor | 1.36e-07 | 196 | 89 | 7 | 0ce3ed27d2b9276390952652c17a8d6de13add36 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 1.41e-07 | 197 | 89 | 7 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.46e-07 | 198 | 89 | 7 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B0|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.97e-07 | 151 | 89 | 6 | 563439b0278776b82c1836c3de9fa80d1a4109af | |
| ToppCell | Immune_cells-T_cells|World / Lineage and Cell class | 9.34e-07 | 163 | 89 | 6 | c5afdb5e7700bbd3ee8276910f9c4b4b3bcc3266 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.04e-06 | 166 | 89 | 6 | f03f78cae6272c89618c0bda032ce45c4fc96baa | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-06 | 166 | 89 | 6 | e01c720de6d4ca144c55378e023e718a64bf32f6 | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.11e-06 | 168 | 89 | 6 | 84977db9d71e59208727885320cc18d80d064380 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-06 | 168 | 89 | 6 | eeb381b62c7ba263af96de1194ed59e57b6ca3ae | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B-B_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-06 | 168 | 89 | 6 | 063d0368d656962b335154c230bdcd9236e7c9ad | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_B|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-06 | 168 | 89 | 6 | a7c4251d8a83bc30196a444028a35c17c24dc291 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-06 | 170 | 89 | 6 | 7a4ed69c807c3761210776e8fe6680d1bd892e82 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells-B-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-06 | 170 | 89 | 6 | 92e0873f618b2fa60c4d555b10f234d5cbcf3325 | |
| ToppCell | LPS-IL1RA-Lymphocytic_B-B_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-06 | 170 | 89 | 6 | c181991f933b779f99afc3782f292306f209e2ac | |
| ToppCell | LPS-IL1RA-Lymphocytic_B|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-06 | 170 | 89 | 6 | 56284fbfd1e53f67c8c0b7fba64505a4002adba2 | |
| ToppCell | tumor_Lung-Endothelial_cells-EPCs|Endothelial_cells / Location, Cell class and cell subclass | 1.24e-06 | 171 | 89 | 6 | dcb6c41980008d0b9eeb54999faff77311554976 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-06 | 174 | 89 | 6 | cc493654ea3517bc6a145c7f787f304929636f86 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells-B-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-06 | 174 | 89 | 6 | 9eb3504f9340517ef5d056503044fbdb9ffeb714 | |
| ToppCell | LPS-antiTNF-Lymphocytic_B-B_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-06 | 174 | 89 | 6 | b4c2d1c029fcd0d4926aa79a5b789c713919dcf3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-06 | 174 | 89 | 6 | 1b2a2129c08bac01fc638692313b196759a1e0d7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-B_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-06 | 174 | 89 | 6 | 5bde24eb588dc588efc413811379548120ec0c7f | |
| ToppCell | facs-Trachea-nan-18m-Lymphocytic-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 176 | 89 | 6 | 14c6c3fdb53f9dfc02b951bc955b90213110c089 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-B_cell-B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-06 | 176 | 89 | 6 | 27c132e9852717cbc345af7a1fc390e9ea589416 | |
| ToppCell | facs-Trachea-nan-18m-Lymphocytic|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 176 | 89 | 6 | 9dd862dcee6947a53189728f6b4cd40e7b67cb71 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 176 | 89 | 6 | 2e3f25a338842384517656d05776a52cbfc62b52 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 176 | 89 | 6 | 0823088bc6b19c7ad784d83c2ccdfae80611afab | |
| ToppCell | facs-Trachea-nan-18m-Lymphocytic-T_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 176 | 89 | 6 | d990e7af8120210100d13caa0465b27cf77a451a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 176 | 89 | 6 | 64e426f5e84884ce2c29acf6f4b958962a63927f | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-B_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.46e-06 | 176 | 89 | 6 | 259d1864fb0a6d2feddc90bc715e2bccbb373792 | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 178 | 89 | 6 | 9423e209de94d26e96117581c95dc069850225d3 | |
| ToppCell | facs-Heart-LA-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 178 | 89 | 6 | d32b4e9c3d1f246ad49e2d8f6497989af68a6c00 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-B_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 178 | 89 | 6 | 5b6f7e8a930c239db1f31edfb61b2b9228d28663 | |
| ToppCell | facs-Heart-LA-18m-Lymphocytic-T_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 178 | 89 | 6 | b7abf5656233e1a9cdbbe978dfa84d16f14b0be0 | |
| ToppCell | PCW_13-14-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_conventional_dendritic_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.61e-06 | 179 | 89 | 6 | 9fc44637c9a7551fd47b8533e45a9c199e164a95 | |
| ToppCell | facs-Heart-RA-18m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-06 | 180 | 89 | 6 | 9be0af61d496a29d737bb772ad09864797994299 | |
| ToppCell | COVID-19-kidney-Bcells|kidney / Disease (COVID-19 only), tissue and cell type | 1.66e-06 | 180 | 89 | 6 | 5650fc7ebcdf5e0be9a217a58d36a8386d59fd1b | |
| ToppCell | Adult-Immune-T_lymphocyte-D122|Adult / Lineage, Cell type, age group and donor | 1.66e-06 | 180 | 89 | 6 | 06c371d0f0c5a7b234dd143e98800e19af95a8b5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.72e-06 | 181 | 89 | 6 | 03a303cd2f366f09c18b118bbba6f5e3f95ad56c | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-06 | 181 | 89 | 6 | ce30724788d9b5c6dfa4f9f8d318c3d2565165ed | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-B_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-06 | 181 | 89 | 6 | 3510e0ecd4f098e8553946c44c2a49587d543755 | |
| ToppCell | Nasal_Brush-Immune-Dendritic_cells|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.83e-06 | 183 | 89 | 6 | b1daec831990a53e846c089cebfcf4f8440820e4 | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-B_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 184 | 89 | 6 | fd72663bf990266da2fba70d4f2260f8d48067ee | |
| ToppCell | facs-SCAT-Fat-3m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-06 | 184 | 89 | 6 | cdacb61878e0824b8416bf365d89965797208359 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-06 | 184 | 89 | 6 | f81209e6bc01a0140f4487aa8b22eb02fbf0c39c | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-B_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-06 | 185 | 89 | 6 | 1eba3b058e23a7d19024b4363dfeb522a8af313d | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 1.95e-06 | 185 | 89 | 6 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-06 | 185 | 89 | 6 | 212a8f6fb9eac0c6a89a20a9aa30d48c21abd375 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-06 | 186 | 89 | 6 | 6e3bea4319d2a1bb060fe0cb1bb8bafafa05f83c | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(other)|Control / group, cell type (main and fine annotations) | 2.01e-06 | 186 | 89 | 6 | c6075fe84226b370c5139066793844ad33ae2db1 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 2.08e-06 | 187 | 89 | 6 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 2.08e-06 | 187 | 89 | 6 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | control-Myeloid-Resident_Macrophage|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.14e-06 | 188 | 89 | 6 | 9bcd6a83da912d136745d1abcb34b3735141048c | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.14e-06 | 188 | 89 | 6 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 2.14e-06 | 188 | 89 | 6 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 2.14e-06 | 188 | 89 | 6 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-06 | 189 | 89 | 6 | 6463890d8dbee4bc198f91628a5f784970de786a | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 2.28e-06 | 190 | 89 | 6 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 2.28e-06 | 190 | 89 | 6 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 191 | 89 | 6 | 530469909ab0994bece37945e9098359077b0824 | |
| ToppCell | facs-MAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 191 | 89 | 6 | b4fba92f9bd1354a07fedfca7304a3757e6d5beb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.35e-06 | 191 | 89 | 6 | a7b18bcf27c38ad2353c239ecb309c80f3ef3359 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-06 | 191 | 89 | 6 | f7a81acb938ce5d383326840dd45f7dd2cf12b1d | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-06 | 193 | 89 | 6 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.49e-06 | 193 | 89 | 6 | 96c85b250d04b5f400512097d925061c6dc2906b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 193 | 89 | 6 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 2.49e-06 | 193 | 89 | 6 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.49e-06 | 193 | 89 | 6 | ff6e6b825d6c88148216c601580be3c28851ab5c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-06 | 193 | 89 | 6 | 456aa8a8f1f9cbba0bd618a5f623909079c0f56b | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 2.57e-06 | 194 | 89 | 6 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | erythropoietic-CD34+_Pro-erythroblast|erythropoietic / Lineage and Cell class | 2.64e-06 | 195 | 89 | 6 | cd3d8fa6e18c0508cdfb64bb879d90b211badee5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-06 | 195 | 89 | 6 | d35102f95bb1e419d2df05ff0a01b6c5c923acef | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.64e-06 | 195 | 89 | 6 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-06 | 196 | 89 | 6 | 65d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.72e-06 | 196 | 89 | 6 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 2.72e-06 | 196 | 89 | 6 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.72e-06 | 196 | 89 | 6 | 8862964090f9a679a548103bfbb12e91295aae62 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.81e-06 | 197 | 89 | 6 | 81718164c9802ee20c860ffbda7e62d5e9a76f16 | |
| ToppCell | Dendritic_cell|World / shred by cell class for turbinate | 2.81e-06 | 197 | 89 | 6 | ab2213e3742f92798922ea318d76328b6ca18b13 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-06 | 198 | 89 | 6 | 92416e65a0dc1a4bf931833407620ea05d362f56 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.89e-06 | 198 | 89 | 6 | a1ccbf0e653b2dd665c2254920eb9b37243cc0bd | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.89e-06 | 198 | 89 | 6 | 1d30a1f73b6d6d838f49751402a29c5ef54aa81f | |
| ToppCell | NS-control-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.89e-06 | 198 | 89 | 6 | 846852943a8ff60f746fd49498240e25ca1c1b09 | |
| ToppCell | Bronchial-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.97e-06 | 199 | 89 | 6 | 36a230b80096455df26c2e2c8c05fd6b231508c5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-06 | 199 | 89 | 6 | 5d976d57872a8a25a11fe8cd53b01aa21a1a519a | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.97e-06 | 199 | 89 | 6 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.97e-06 | 199 | 89 | 6 | d58edc5f74970bb26d844746184e4bae7c494d6b | |
| ToppCell | Parenchymal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-06 | 200 | 89 | 6 | 0e648e9eb96c83a94505d07323785a7a40997eb0 | |
| ToppCell | medial-Hematologic-CD8+_Naive_T|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.06e-06 | 200 | 89 | 6 | 2de8fae1011c57270170fb200a8897add7fe9bfc | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD4-CD4_naive/CM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-06 | 200 | 89 | 6 | cded40d5069a6fdbd90ac9a2a0bbef11727b28d5 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD4-T_reg|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-06 | 200 | 89 | 6 | 68589705dbc84482b6c0a1a27dd552492c4e8c3d | |
| ToppCell | medial-2-Hematologic-CD8+_Naive_T|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.06e-06 | 200 | 89 | 6 | 5e5c1c5b6d2fcfad7b93488b976a68f5be1435e5 | |
| ToppCell | medial-Hematologic-CD8+_Naive_T-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.06e-06 | 200 | 89 | 6 | 2daa445f983a43ff3ace1198a6793f5c6706bdba | |
| Computational | Genes in the cancer module 27. | HFE VIPR1 IL13RA2 PTPRC CSF2RB PTPRF DDR2 CCR8 GPR183 CALCRL ADGRL2 CR2 TNFRSF21 ITGB8 CHRNA4 CNR1 ADCYAP1R1 | 3.46e-13 | 355 | 52 | 17 | MODULE_27 |
| Computational | Membranal receptors. | VIPR1 IL13RA2 EREG PTPRC CSF2RB DDR2 CD53 CCR8 GPR183 CALCRL CR2 TNFRSF21 CHRNA4 CNR1 | 9.72e-08 | 517 | 52 | 14 | MODULE_64 |
| Computational | Genes in the cancer module 146. | 5.31e-07 | 102 | 52 | 7 | MODULE_146 | |
| Computational | Porins / transporters. | IL13RA2 CSF2RB PTPRF PTPRK DDR2 TNFRSF21 ITGB8 CHRNA4 ADCYAP1R1 | 6.46e-07 | 211 | 52 | 9 | MODULE_63 |
| Drug | CHAPSO | 3.49e-07 | 38 | 88 | 5 | CID000122145 | |
| Drug | AC1L4RIC | 5.55e-07 | 5 | 88 | 3 | CID000162562 | |
| Drug | 2-(oxalylamino)benzoic acid | 1.93e-06 | 7 | 88 | 3 | ctd:C405943 | |
| Drug | nM-1 | 2.37e-06 | 155 | 88 | 7 | CID000445754 | |
| Drug | S-V3 | 4.61e-06 | 9 | 88 | 3 | CID000209655 | |
| Drug | Amprolium hydrochloride [137-88-2]; Up 200; 12.6uM; PC3; HG-U133A | 1.07e-05 | 195 | 88 | 7 | 1898_UP | |
| Drug | Niflumic acid [4394-00-7]; Up 200; 14.2uM; HL60; HT_HG-U133A | 1.22e-05 | 199 | 88 | 7 | 2399_UP | |
| Drug | AC1L9L52 | 1.48e-05 | 2 | 88 | 2 | CID000447705 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 6.57e-09 | 195 | 87 | 9 | DOID:1574 (implicated_via_orthology) | |
| Disease | Gastro-enteropancreatic neuroendocrine tumor | 1.10e-05 | 15 | 87 | 3 | C2930967 | |
| Disease | Headache, HbA1c measurement | 3.17e-05 | 21 | 87 | 3 | EFO_0004541, HP_0002315 | |
| Disease | Eczema, allergic rhinitis | 4.31e-05 | 215 | 87 | 6 | EFO_0005854, HP_0000964 | |
| Disease | Alcoholic Intoxication, Chronic | 1.45e-04 | 268 | 87 | 6 | C0001973 | |
| Disease | erythronate measurement | 1.79e-04 | 7 | 87 | 2 | EFO_0021025 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 1.79e-04 | 7 | 87 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | Kunitz-type protease inhibitor 1 measurement | 3.05e-04 | 9 | 87 | 2 | EFO_0008199 | |
| Disease | rheumatoid arthritis | 4.38e-04 | 462 | 87 | 7 | EFO_0000685 | |
| Disease | obesity (implicated_via_orthology) | 4.46e-04 | 215 | 87 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Akinetic-Rigid Variant of Huntington Disease | 5.56e-04 | 12 | 87 | 2 | C0751207 | |
| Disease | Juvenile Huntington Disease | 5.56e-04 | 12 | 87 | 2 | C0751208 | |
| Disease | Huntington Disease, Late Onset | 5.56e-04 | 12 | 87 | 2 | C0393574 | |
| Disease | Hepatitis C | 8.80e-04 | 15 | 87 | 2 | C0019196 | |
| Disease | respiratory system disease | 9.08e-04 | 145 | 87 | 4 | EFO_0000684 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 1.00e-03 | 16 | 87 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | muscular dystrophy (is_implicated_in) | 1.14e-03 | 17 | 87 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Huntington Disease | 1.14e-03 | 17 | 87 | 2 | C0020179 | |
| Disease | urate measurement | 1.29e-03 | 895 | 87 | 9 | EFO_0004531 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 1.63e-03 | 170 | 87 | 4 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | age of onset of asthma | 1.67e-03 | 79 | 87 | 3 | OBA_2001001 | |
| Disease | Attention Deficit Disorder | 1.91e-03 | 22 | 87 | 2 | C0041671 | |
| Disease | Minimal Brain Dysfunction | 1.91e-03 | 22 | 87 | 2 | C1321905 | |
| Disease | Liver Cirrhosis, Experimental | 2.04e-03 | 774 | 87 | 8 | C0023893 | |
| Disease | inflammatory bowel disease | 2.15e-03 | 449 | 87 | 6 | EFO_0003767 | |
| Disease | Eczema | 2.27e-03 | 310 | 87 | 5 | HP_0000964 | |
| Disease | Attention deficit hyperactivity disorder | 2.27e-03 | 24 | 87 | 2 | C1263846 | |
| Disease | obesity (is_implicated_in) | 2.49e-03 | 91 | 87 | 3 | DOID:9970 (is_implicated_in) | |
| Disease | Limb-girdle muscular dystrophy | 2.67e-03 | 26 | 87 | 2 | cv:C0686353 | |
| Disease | Inhalant adrenergic use measurement | 2.90e-03 | 96 | 87 | 3 | EFO_0009941 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LFVLIVLSQLTILII | 436 | Q0P6H9 | |
| VLLSLTVFLLLITEI | 281 | P43681 | |
| IILLAEVTLAILLFV | 91 | P19397 | |
| LLTVVVIFRILIVAI | 26 | Q9UKL4 | |
| SKYLTFLLVVTILIV | 306 | P07510 | |
| FLLVTIVILIIILKF | 1121 | Q86UK0 | |
| AFLTIIILLIVLFLD | 51 | Q9UHQ4 | |
| IILLNIIFLVITLCK | 1001 | O95490 | |
| TILINFLIFIRILGI | 306 | P48546 | |
| FLIFIRILGILLSKL | 311 | P48546 | |
| ISLLVILFIVILGFI | 201 | O43246 | |
| IIFTILILLTILEIA | 191 | P00846 | |
| IVFAIVFIITRLVIL | 266 | Q96G23 | |
| ILVLLILAVITIFAL | 6 | Q16853 | |
| ILILVIFVTGLLLRK | 351 | Q14627 | |
| ILLLLVSRLLFVVIS | 161 | O14683 | |
| IIVLTITLLGVVYKR | 491 | Q8NHS3 | |
| VLFLLAVILAIALRL | 701 | Q9Y5F9 | |
| VLFLLAVILAIALRL | 701 | Q9Y5F8 | |
| LKLAVLGIFIIVVFV | 156 | Q68G75 | |
| FVRALIFVIPSILLI | 151 | Q8NGJ4 | |
| LLAVAVVIILFIILL | 1681 | Q04721 | |
| VFVRKVYTILLIQLL | 101 | Q9BWQ8 | |
| VPVVVVFLFLILIRR | 216 | Q14439 | |
| LLIIFCLIVVTIDIL | 11 | Q2M2H8 | |
| VAIIFILLAIIVIIL | 406 | Q16832 | |
| FVVLILLITAKLLVL | 276 | Q7Z3F1 | |
| TLEIVLSVLLLVLFI | 11 | O43451 | |
| LSVLLLVLFIISIVL | 16 | O43451 | |
| LVLFIISIVLIVLLA | 21 | O43451 | |
| FFVVLIVILVLLVID | 51 | P51572 | |
| ILYVKLSLFVVILVT | 241 | Q6Q8B3 | |
| IIFIVIIITLVVLLL | 236 | P52799 | |
| LKILFVIFVDLISII | 26 | P0DMT0 | |
| IIFISYVLILKTVLS | 211 | Q9H339 | |
| IVASLLIIIFILSKF | 196 | O14524 | |
| VLIILLFISIILTFK | 246 | Q86VI4 | |
| LIFAISVTVILIILI | 906 | Q96QE4 | |
| SVTVILIILIIIFCL | 911 | Q96QE4 | |
| FVVILFIGILFIILR | 316 | Q30201 | |
| IFETVVIVLLTFLII | 41 | Q9Y2T5 | |
| FPRIIKVLFTIFLVI | 21 | Q8NGI8 | |
| ILACVLIIFLIYKVV | 536 | Q7Z2Q7 | |
| RVYLKQIIVKVILFV | 256 | Q6P9F7 | |
| FVLFIGIIVILVQKL | 321 | P41586 | |
| SFIFLLTIIILSIIK | 716 | Q9Y5I4 | |
| IVTFLIGLLKVLIIR | 691 | P26012 | |
| IFLILICLTVIVTLV | 306 | P15812 | |
| ALIVIFLTIAVLLAL | 446 | P32927 | |
| IFGILIITILLVRFK | 1136 | O75054 | |
| VLFVVFSLVILIILR | 41 | A6NFR6 | |
| LLTFLIVITLYVISK | 986 | P20023 | |
| IIILLVIVVLFAALK | 621 | Q9Y6N8 | |
| AIRLVLIVVIASLLF | 236 | P51685 | |
| LAKTLVLILVVLIIC | 341 | P21554 | |
| LCVLILLAIVVLFIT | 621 | Q13634 | |
| ILLIISIDRFLIIVQ | 171 | Q9BZJ6 | |
| ILSILEVIIILLLIF | 321 | Q8IWA5 | |
| EVIIILLLIFLRKRI | 326 | Q8IWA5 | |
| KEYVALTVILIILFL | 116 | O14944 | |
| IILLLVIVVLFVTLR | 631 | P55286 | |
| LLFVISITTIIVIFL | 261 | Q15762 | |
| LSSLIVILLVVFALV | 2016 | Q7Z5N4 | |
| IALVGLIFILLLVFV | 1936 | Q58EX2 | |
| LIFILLLVFVLIIRG | 1941 | Q58EX2 | |
| AIILFIILFILLLFL | 2046 | O75923 | |
| LFFLLNIVRVLITKL | 306 | Q16602 | |
| SLLVIVFIIIVLYML | 161 | P18433 | |
| VILIILIVIAILLFK | 1271 | P10586 | |
| LVFILLLLVVILIVK | 761 | Q15262 | |
| VTLISYLFILITILK | 211 | Q8NGF7 | |
| KTLFVLFLIVYLVTI | 26 | Q8NGR8 | |
| IIAFILIILIIFLVL | 1826 | Q2WGJ9 | |
| ILLLVIIILIVMKYR | 126 | O75379 | |
| AFGIFRLLIIILIIV | 211 | Q9NX52 | |
| IVFGFIILLLLVLRK | 236 | Q96DU3 | |
| LFLLLVLVVIVVCSI | 356 | O75509 | |
| AVIILFITAVLLLIL | 26 | P0DI80 | |
| KALNTIILIIVVFVL | 241 | P32249 | |
| LLVLINVVLIFLLAF | 41 | A0A1B0GW54 | |
| LLFILAVINLIITLV | 71 | Q16585 | |
| LVAILLVFLITAILV | 116 | Q99808 | |
| LLLGVTLFITVLVLF | 406 | Q96F05 | |
| TLVLIVLVTLIFCLI | 61 | Q6NUJ2 | |
| LLKLFVAIVITFILI | 6 | Q8N614 | |
| LLVFIFLIILTIRKI | 221 | Q8N614 | |
| YKFIVITVIILITLI | 76 | Q86X19 | |
| LVNFILFICIIRILL | 306 | P32241 | |
| IKVTIIIYLSILGLL | 101 | Q9NQ34 | |
| YIISSVIQKFVLLIL | 276 | Q96AG3 | |
| RVVLLAILLVIFIFT | 6 | O75063 | |
| FVLFISIIRILLQKL | 296 | P41587 | |
| FILLLGIILTVSLVF | 191 | Q9H0R3 | |
| ISIFIIFLLVIGTLL | 461 | Q9H330 | |
| LIIVTSIALLVVLYK | 586 | P08575 | |
| ILLVFIRELKNLFVL | 221 | Q6YBV0 | |
| FFIVLLVILLAELIL | 86 | O75954 | |
| VRIKVLDVLSFVLLI | 461 | P49815 | |
| FLRFLVLLNLVIFLI | 166 | Q7Z402 | |
| LILFLVALLARVLVK | 41 | Q9BZW5 |